[1]
Tanner L,Müller MM, [Blood Transfusion: a Guide to Clinical Decision Making]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS. 2019 Mar; [PubMed PMID: 30866023]
[2]
Coppo P,Cuker A,George JN, Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine. Research and practice in thrombosis and haemostasis. 2019 Jan; [PubMed PMID: 30656273]
[3]
Wiernek SL,Jiang B,Gustafson GM,Dai X, Cardiac implications of thrombotic thrombocytopenic purpura. World journal of cardiology. 2018 Dec 26; [PubMed PMID: 30622684]
[4]
Gavriilaki E,Anagnostopoulos A,Mastellos DC, Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics. Frontiers in immunology. 2019; [PubMed PMID: 30891033]
[5]
Amin Asnafi A,Jalali MT,Pezeshki SMS,Jaseb K,Saki N, The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT. Journal of pediatric hematology/oncology. 2019 Mar; [PubMed PMID: 30543580]
[6]
Swart L,Schapkaitz E,Mahlangu JN, Thrombotic thrombocytopenic purpura: A 5-year tertiary care centre experience. Journal of clinical apheresis. 2019 Feb; [PubMed PMID: 30536422]
[7]
Chiasakul T,Cuker A, Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology. American Society of Hematology. Education Program. 2018 Nov 30; [PubMed PMID: 30504354]
[8]
Dane K,Chaturvedi S, Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura. Hematology. American Society of Hematology. Education Program. 2018 Nov 30; [PubMed PMID: 30504355]
[9]
Plautz WE,Raval JS,Dyer MR,Rollins-Raval MA,Zuckerbraun BS,Neal MD, ADAMTS13: origins, applications, and prospects. Transfusion. 2018 Oct; [PubMed PMID: 30208220]
[10]
Chang JC, TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease. Thrombosis journal. 2018; [PubMed PMID: 30127669]
[11]
Jia X,He Y,Ruan CG, [Research Advances of Acquired Thrombotic Thrombocytopenic Purpura--Review]. Zhongguo shi yan xue ye xue za zhi. 2018 Aug; [PubMed PMID: 30111436]
[12]
Fox LC,Cohney SJ,Kausman JY,Shortt J,Hughes PD,Wood EM,Isbel NM,de Malmanche T,Durkan A,Hissaria P,Blombery P,Barbour TD, Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand. Nephrology (Carlton, Vic.). 2018 Jun; [PubMed PMID: 29419916]
[13]
Matsumoto M, New developments in treatment modalities of thrombotic thrombocytopenic purpura. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; [PubMed PMID: 28978852]
[14]
Miyakawa Y, TTP and aHUS: new insights. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; [PubMed PMID: 28592771]
[15]
Matsumoto M, Consensus report on the diagnosis and management of thrombotic thrombocytopenic purpura 2017. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2017; [PubMed PMID: 28484152]
[16]
Adamski J, Thrombotic microangiopathy and indications for therapeutic plasma exchange. Hematology. American Society of Hematology. Education Program. 2014 Dec 5; [PubMed PMID: 25696892]
[17]
Bayer G,von Tokarski F,Thoreau B,Bauvois A,Barbet C,Cloarec S,Mérieau E,Lachot S,Garot D,Bernard L,Gyan E,Perrotin F,Pouplard C,Maillot F,Gatault P,Sautenet B,Rusch E,Buchler M,Vigneau C,Fakhouri F,Halimi JM, Etiology and Outcomes of Thrombotic Microangiopathies. Clinical journal of the American Society of Nephrology : CJASN. 2019 Mar 12; [PubMed PMID: 30862697]
[18]
George JN, TTP: long-term outcomes following recovery. Hematology. American Society of Hematology. Education Program. 2018 Nov 30; [PubMed PMID: 30504356]